Clinical trials
6 active studies led by PT Bio Farma, of 47 in all
Source: ClinicalTrials.gov, Studies with PT Bio Farma (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 7Markets in public records
- 0Regions & countries
- 6Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by PT Bio Farma or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on PT Bio Farma
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies PT Bio Farma leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with PT Bio Farma or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show PT Bio Farma: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets PT Bio Farma is in.
From our blog
Stories on the topics PT Bio Farma works in.
Molecular Point-of-Care Tests: Lab Accuracy, Clinic Speed
TB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
Read
Antimicrobial Resistance: Why Faster Testing Matters
Drug-resistant infections already kill over a million people a year. Faster testing helps doctors pick the…
Read
Needleless Connectors: Small Device, Big Infection Impact
Needleless connectors protect staff from needle injuries, but if not cleaned they can let germs into the…
Read